Eddy has been promoted to Full Professor of Medicinal Chemistry.
Eddy has been appointed Associate Editor of the journal Purinergic Signalling
Combiomed Family Picture, October 2022
Ana and Rubén awarded with the ACS poster prize at the XX Meeting of the SEQT
Our cancer immunotherapy project starts to emerge: First publication in Journal for ImmunoTherapy of Cancer
The first two papers of the group in 2022 have just been published in ACS journals: J. Med. Chem (A1 antagonists) and ACS Med. Chem. Lett. (A3 antagonists)
Congratulations to our new PhD Ana Mallo who brilliantly presented her doctoral thesis
Second paper of the group in J. Med. Chem during 2021 has just been published
We are happy to announce the creation of a new spin-off based on technologies developed in ComBioMed.
The first paper of the group in 2021 has just been published in J. Med. Chem.
Eddy will preside the organizing committee of the XX congress of the Spanish´s Medicinal Chemistry Society.
A new paper of the group in J. Med. Chem.
New paper of the Group in Angew. Chem. Int. Ed.
Eddy has recently been elected Review Editor and member ofthe Editorial Board of the Journal Frontiers in Neuroscience
New paper of the Group in ACS Pharmacology & Translational Science
Eddy will deliver a lecture at the international symposium on oligomerization of GPCRs to be held at the Karolinska Institute
Congratulations to María Majellaro and Ana Mallo, both awarded the COST travel grant to attend the First ERNEST Meeting in Belfast.
New paper of the Group in the J. Med. Chem.
Maria and Rubén awarded the best poster prize in the 1st European Purine Meeting
Eddy elected as Review Editor and member of the Editorial Board of Medicinal and Pharmaceutical Chemistry, part of the journal Frontiers in Chemistry.
Claudia awarded with the best flash communication prize in the 19 Meeting of the Spanish Society of Medicinal Chemistry (SEQT).
Eddy will deliver a keynote lecture at the First European Purine Meeting.
Eddy elected as Group Leader of the Methodologies and Technologies WG and member of the management committee of the European COST Action ERNEST (CA181133).
Great representation of the Group in the next Congress of the Spanish Medicinal Chemistry Society (SEQT) in Vittoria.